John Bothos
Impact in
- Cell Biology top 5%
- Microtubule and mitosis dynamics
- Hippo pathway signaling and YAP/TAZ
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Ubiquitin and proteasome pathways 5
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- Thanos D. Halazonetis (5 shared papers)Matthew K. Summers (4 shared papers)Francis C. Luca (3 shared papers)Michelle Ottey (1 shared paper)Daniel M. Scolnick (2 shared papers)Monica Venere (1 shared paper)Premal H. Patel (7 shared papers)Elena S. Stavridi (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)Oncogene (2 papers)Molecular Cancer Research (1 paper)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
John Bothos
19 papers receiving 528 citations
Peers
Comparison fields: 5 of 55
- Cell Biology 252
- Hepatology 59
- Oncology 179
- Molecular Biology 334
- Pulmonary and Respiratory Medicine 94
Countries citing papers authored by John Bothos
This map shows the geographic impact of John Bothos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Bothos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Bothos more than expected).
Fields of papers citing papers by John Bothos
This network shows the impact of papers produced by John Bothos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Bothos. The network helps show where John Bothos may publish in the future.
Co-authors
The 25 scholars most cited alongside John Bothos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 106 | |
| 2 | 2003 | 80 | |
| 3 | 2003 | 63 | |
| 4 | 2014 | 56 | |
| 5 | 2005 | 49 | |
| 6 | Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer. | 2003 | 40 |
| 7 | 2021 | 33 | |
| 8 | 2013 | 33 | |
| 9 | 2021 | 19 | |
| 10 | 2007 | 17 | |
| 11 | 2020 | 9 | |
| 12 | 2010 | 8 | |
| 13 | 2011 | 8 | |
| 14 | 2011 | 7 | |
| 15 | 2024 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2011 | 4 | |
| 18 | 2010 | 1 | |
| 19 | 2018 | 1 |
About John Bothos
John Bothos is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cell Biology, Hepatology and Oncology, having authored 19 papers that have together received 542 indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (6 papers), Liver physiology and pathology (5 papers), Ubiquitin and proteasome pathways (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Prostate Cancer Treatment and Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cell Biology (252 citations), Hepatology (59 citations), Oncology (179 citations), Molecular Biology (334 citations) and Pulmonary and Respiratory Medicine (94 citations). John Bothos has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Thanos D. Halazonetis, Matthew K. Summers, Francis C. Luca, Michelle Ottey, Daniel M. Scolnick, Monica Venere, Premal H. Patel, Elena S. Stavridi, Surinder Kaur and Amy Peterson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Oncogene and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.